BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to A-431 cell line is 32
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CD44 | 1681 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | IHC staining and FACs | NA | 0.36 | 1 | 22740085 |
| ITGB1 | 6153 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | IHC staining and FACs | NA | 0.36 | 0.018 | 22740085 |
| LGR5 | 4504 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | IF staining and FACs followed by SFA | NA | 0.36 | 0.0753 | 25966742 |
| CTNNB1 | 2514 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | Western Blotting and SFA | NA | 0.28 | 0.0647 | 25966742 |
| GLI1 | 4317 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | CFA and Western Blotting | NA | 0.28 | 0.0308 | 29914183 |
| SHH | 10848 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | CFA and Western Blotting | NA | 0.28 | 0.0201 | 29914183 |
| SMO | 11119 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | CFA and Western Blotting | NA | 0.28 | 0.0212 | 29914183 |
| PROM1 | 9454 | LTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | MACs | NA | 0.12 | 0.7582 | 29458573 |
| ADAMTSL3 | 14633 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 22740085 |
| ASNS | 753 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22740085 |
| AXL | 905 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22740085 |
| CCNA2 | 1578 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 22740085 |
| CDC2 | 1722 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 22740085 |
| CDH1 | 1748 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 22740085 |
| CDH2 | 1759 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0085 | 22740085 |
| CTNNAL1 | 2512 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22740085 |
| DEPDC1 | 22949 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 22740085 |
| DHRS9 | 16888 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 22740085 |
| ECM2 | 3154 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 22740085 |
| ERBB3 | 3431 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 22740085 |
| IVL | 6187 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 22740085 |
| KRT15 | 6421 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 22740085 |
| MAN2C1 | 6827 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 22740085 |
| MMP7 | 7174 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 22740085 |
| NF1 | 7765 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 22740085 |
| NT5E | 8021 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0095 | 22740085 |
| PLXNB1 | 9103 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 22740085 |
| RAB6C | 16525 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22740085 |
| RAD1 | 9806 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22740085 |
| SAT1 | 10540 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 22740085 |
| TNFSF10 | 11925 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 22740085 |
| VIM | 12692 | HTM | Skin Cancer | Squamous Cell Carcinoma | A-431 | NA | FACs for CSC marker and CFA followed by Transcriptomics | Up | 0.04 | 0.017 | 22740085 |